Nguyen D, Nguyen T, Le T, Nguyen Q, Le Bui N, Chu D
Heliyon. 2024; 10(2):e24691.
PMID: 38304811
PMC: 10831734.
DOI: 10.1016/j.heliyon.2024.e24691.
Chen J, Hsia K, Kuo Y, Chen S, Huang Y, Li C
Nutrients. 2024; 16(1).
PMID: 38201957
PMC: 10780348.
DOI: 10.3390/nu16010126.
Ahn J, Park J
Prev Nutr Food Sci. 2024; 28(4):492-501.
PMID: 38188089
PMC: 10764228.
DOI: 10.3746/pnf.2023.28.4.492.
Panja K, Areerat S, Chundang P, Palaseweenun P, Akrimajirachoote N, Sitdhipol J
Vet World. 2023; 16(4):834-843.
PMID: 37235154
PMC: 10206979.
DOI: 10.14202/vetworld.2023.834-843.
Anwar Y, Ullah I, Kamal T, Ullah M
Biomimetics (Basel). 2022; 7(4).
PMID: 36278709
PMC: 9624373.
DOI: 10.3390/biomimetics7040152.
Cholesterol-lowering effects and safety assessment of Lactobacillus spp. in vivo and in vitro testing for human use as probiotic from the dairy product in Egypt.
Fadl M, Kamel Z
J Genet Eng Biotechnol. 2022; 20(1):144.
PMID: 36255551
PMC: 9579229.
DOI: 10.1186/s43141-022-00423-3.
Extract Pretreatment Alleviates Oxidative Stress and Inflammation and Increases the Abundance of Gut in Diquat-Induced Mice.
Lu S, Xu S, Chen L, Deng Y, Feng J
Antioxidants (Basel). 2022; 11(9).
PMID: 36139880
PMC: 9495987.
DOI: 10.3390/antiox11091806.
Safety evaluation of mutagenicity, genotoxicity, and cytotoxicity of Lactobacillus spp. isolates as probiotic candidates.
Darbandi A, Mirkalantari S, Zadeh R, Esghaei M, Talebi M, Kakanj M
J Clin Lab Anal. 2022; 36(7):e24481.
PMID: 35582746
PMC: 9279957.
DOI: 10.1002/jcla.24481.
Probiotic and Functional Properties of INIA P572.
Diez-Echave P, Martin-Cabrejas I, Garrido-Mesa J, Langa S, Vezza T, Landete J
Nutrients. 2021; 13(6).
PMID: 34072532
PMC: 8228662.
DOI: 10.3390/nu13061860.
Safety evaluation of aqueous extracts of fruiting body in Sprague-Dawley rats.
Huo J, Sun Y, Zhong S, Li Y, Yang R, Xia L
Food Sci Nutr. 2020; 8(9):5107-5113.
PMID: 32994971
PMC: 7500762.
DOI: 10.1002/fsn3.1811.
Akkermansia muciniphila is a promising probiotic.
Zhang T, Li Q, Cheng L, Buch H, Zhang F
Microb Biotechnol. 2019; 12(6):1109-1125.
PMID: 31006995
PMC: 6801136.
DOI: 10.1111/1751-7915.13410.
Lack of mutagenicity, genotoxicity and developmental toxicity in safety assessment tests of Lactobacillus mali APS1.
Lin Y, Chen Y, Chen M
PLoS One. 2018; 13(12):e0208881.
PMID: 30543670
PMC: 6292621.
DOI: 10.1371/journal.pone.0208881.
Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union.
Brodmann T, Endo A, Gueimonde M, Vinderola G, Kneifel W, de Vos W
Front Microbiol. 2017; 8:1725.
PMID: 28955311
PMC: 5601064.
DOI: 10.3389/fmicb.2017.01725.
Safety Assessment of Two New Lactobacillus Strains as Probiotic for Human Using a Rat Model.
Shokryazdan P, Jahromi M, Liang J, Kalavathy R, Sieo C, Wan Ho Y
PLoS One. 2016; 11(7):e0159851.
PMID: 27467068
PMC: 4965145.
DOI: 10.1371/journal.pone.0159851.
Characterization of a Reuterin-Producing Lactobacillus reuteri BPL-36 Strain Isolated from Human Infant Fecal Sample.
Mishra S, Malik R, Manju G, Pandey N, Singroha G, Behare P
Probiotics Antimicrob Proteins. 2016; 4(3):154-61.
PMID: 26782041
DOI: 10.1007/s12602-012-9103-1.
Safety evaluation of Lactobacillus paracasei subsp. paracasei LC-01, a probiotic bacterium.
Zhang H, Wang Y, Sun J, Guo Z, Guo H, Ren F
J Microbiol. 2013; 51(5):633-8.
PMID: 24173643
DOI: 10.1007/s12275-013-3336-x.
Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).
Huys G, Botteldoorn N, Delvigne F, De Vuyst L, Heyndrickx M, Pot B
Mol Nutr Food Res. 2013; 57(8):1479-504.
PMID: 23801655
PMC: 3910143.
DOI: 10.1002/mnfr.201300065.
Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.
Lee D, Jang S, Baek E, Kim M, Lee K, Shin H
Lipids Health Dis. 2009; 8:21.
PMID: 19515264
PMC: 2707375.
DOI: 10.1186/1476-511X-8-21.
Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.
Prakash S, Jones M
J Biomed Biotechnol. 2005; 2005(1):44-56.
PMID: 15689638
PMC: 1138267.
DOI: 10.1155/JBB.2005.44.
Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms.
Asahara T, Takahashi M, Nomoto K, Takayama H, Onoue M, Morotomi M
Clin Diagn Lab Immunol. 2003; 10(1):169-73.
PMID: 12522056
PMC: 145284.
DOI: 10.1128/cdli.10.1.169-173.2003.
